Table: Brightpath Biotherapeutics - Q1 parent results

BrightPath Biotherapeutics

14/08/2026 07:33

    Aug 14 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2026        Jun 30, 2025      Mar 31, 2027  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             0 mln     
                 (-66.7 pct)         (+20.0 pct)                    
  Operating     loss 547 mln        loss 245 mln        loss 1.97   
  Recurring     loss 545 mln        loss 240 mln        loss 1.95   
  Net           loss 530 mln        loss 241 mln        loss 1.95   
  EPS           loss 3.82 yen       loss 2.59 yen    loss 13.24 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T